Company Overview and News
The Indian stock market continues to stay weak in this afternoon session with the Nifty50 down 12 points, trading at 10,460 while the Sensex shed 29 points at 34,704.
PWQFY 500408 500325 524816 532955 511389 533137 CADILAHC DEN 535789 532321 500696 GAILF RLNIY EXIDEIND 538771 511072 532706 TATAPOWER YYBKY DHFL EXQDY GAILY TCS RECLTD RELIANCE INOXLEISUR HINDUNILVR 532218 VIDEOIND 532810 TTNQY SOUTHBANK 532540 NATCOPHARM PINCON RIGD TV18BRDCST YESBANK IBN IDKQY 532648 532800 CDLYY IBULHSGFIN PFC ICICIBANK 532174 TPCL TATAELXSI 500400 500086
The Indian benchmark indices are trading in the red this Monday morning with the Nifty50 down 25 points, trading at 10,446 while the Sensex shed 47 points at 34,685.
IOC BAJAJ-AUTO 500408 500325 524816 RELIANCE TCHQY 532218 532977 532755 CADILAHC 535789 505200 SOUTHBANK 532343 532321 NATCOPHARM PINCON RIGD GAILF EICHERMOT RLNIY ECQRY 538771 TVSMOTOR IDKQY 530965 CDLYY TECHM IBULHSGFIN GAILY TATAELXSI DCMSHRIRAM 523367
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Share prices of all listed liquor companies fell up to 6 percent intraday on Thursday after the Karnataka government increased additional excise duty on liquor.
532432 538771 PINCON UBL UNITDSPR UQNTY UBHOLDINGS GLOBUSSPR 507458 UNBWY 532478 533104
Indian benchmark indices witnessed a good up move Wednesday after a series of volatile sessions over the last week. However, these 8 stocks have been steadily declining over the past 8 sessions.
GOLDTECH 538771 PINCON 531816 PANORAMUNI 506194 JBFIND 530381 531439 514034 ASL PETRONENGG
The Indian benchmark indices have managed to reverse the bearish trend this this Tuesday afternoon with the Nifty adding 37 points at 10,694 and the Sensex is trading higher by 112 points at 35,377.
BAJAJ-AUTO IOC 500325 532832 533137 DEN JUSTDIAL MANGLMCEM JBFIND 500696 GAILF 500570 500493 502157 BHARATFORG RLNIY 538771 RELCAPITAL 524804 FORCEMOT APOLLOTYRE AYRQY 530965 530005 500182 BATAINDIA TATASTEEL TATLY GAILY 523204 IBREALEST WABAG AUROPHARMA GODREJIND RELIANCE HINDUNILVR 532977 532856 514034 ABAN 500470 535648 PINCON 533309 RIGD HEROMOTOCO INDIACEM TATAMOTORS 500033 500111 517354 HVLQY DALMIABHA 500877 VTUWY 533269 TTST ARBQY HAVELLS HRTQY 500043 500164 JSTQY TTM TIMETECHNO
The broader indices including the Nifty and the Sensex are trading on a negative note this Friday afternoon with the Nifty down 10 points at 10,731 and the Sensex is trading lower by 30 points at 35,401.
SUZLON 500325 TTQQY SHREECEM JSWENERGY TATACHEM 539437 534816 UCLQY BJJQY BEL 500493 SUEL 500770 BHARATFORG RLNIY SBAZ BHQRY 538771 TATAPOWER UNITDSPR APOLLOTYRE YYBKY AYRQY 532667 ULTRACEMCO 532432 BAJFINANCE 500387 UQNTY TCS 500188 HINDZINC ABBOTINDIA BHRYY 532939 RELIANCE PUNJLLOYD 532538 HNDZY 533155 BHRQY TTNQY JUBLFOOD 532540 532187 IDFCBANK 532461 PINCON 533309 RIGD JBLWY INFRATEL BHARTIARTL 500034 YESBANK RPOWER DALMIABHA INDUSINDBK 500877 IBN UCLQF 532648 533148 532454 ICICIBANK PNJZY 532693 532174 TPCL PNB 500400 500488 500049
2018-06-07 moneycontrol - 1
The broader indices continue to trade on a positive note this Thursday afternooon with the Nifty trading higher by 118 points at 10,802 and the Sensex gained 400 points at 35,579.
500325 FEDA 511389 535789 JUSTDIAL 532480 FEDS 523574 BJJQY GAILF 500570 FEDERALBNK RLNIY GRUH 538771 AXB RELCAPITAL ALBK FDBAY YYBKY 530005 JSWSTEEL AXBA BAJFINANCE TATASTEEL TATLY FRLDVR GAILY ANDHRABANK HINDCOPPER 500469 FSL 533150 500228 RELIANCE IDBI 533273 512573 532418 532856 VIDEOIND 532215 511288 500470 535648 AXISBANK PINCON RIGD INDIACEM TATAMOTORS 500034 500111 YESBANK UBNC 532809 570002 500116 AVANTI FRL IBN IDKQY 513599 532648 GRHFY 539207 AXBKY IBULHSGFIN ICICIBANK OBZIY GODREJPROP TTST OBEROIRLTY 532174 MANPASAND JSTQY TTM TIMETECHNO
The broader indices continue to trade on a positive note this Thursday afternooon with the Nifty trading higher by 111 points at 10,796 and the Sensex gained 375 points at 35,554.
500325 FEDA 511389 533137 DEN JUSTDIAL FEDS 523574 BJJQY GAILF 500570 FEDERALBNK SUNTV RLNIY GRUH 538771 AXB RELCAPITAL FDBAY YYBKY 530005 JSWSTEEL AXBA BAJFINANCE TATASTEEL TATLY FRLDVR GAILY HINDCOPPER 500469 FSL 533150 500228 RELIANCE 533273 512573 532856 VIDEOIND 532733 532215 511288 500470 535648 AXISBANK PINCON INOXWIND RIGD INDIACEM TATAMOTORS 500034 500111 YESBANK 532809 570002 AVANTI FRL IBN 513599 532648 GRHFY 539207 AXBKY ICICIBANK OBZIY GODREJPROP TTST OBEROIRLTY 532174 SNQVY 539083 MANPASAND JSTQY TTM TIMETECHNO
The broader indices are trading on a positive note this Thursday morning with the Nifty trading higher by 78 points at 10,762 and the Sensex gained 275 points at 35,454.
500325 511389 532832 533137 DEN JUSTDIAL 523574 BJJQY RLNIY GRUH 538771 AXB YYBKY JSWSTEEL AXBA BAJFINANCE TATASTEEL TATLY FRLDVR 500180 IBREALEST HINDCOPPER FSL 533150 500228 RELIANCE 533273 512573 532856 VIDEOIND 532215 511288 500470 535648 AXISBANK PINCON RIGD HDFCBANK 500034 YESBANK 532809 570002 HINDALCO AVANTI FRL IBN 513599 532648 GRHFY AXBKY HNDNF ICICIBANK OBZIY GODREJPROP TTST OBEROIRLTY HDB 532174 JSTQY 500440 TIMETECHNO
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...